Patents by Inventor Christopher J. Rivard

Christopher J. Rivard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes
    Patent number: 8697628
    Abstract: The present invention provides compounds and compositions that modulate adenosine monophosphate deaminase (AMPD) and methods for using the same to treat a clinical condition associated with the metabolic syndrome or a disease associated with the metabolic syndrome. In particular, the present invention provides a compound and a composition comprising a selective AMPD2 inhibitor and methods for using the same, for example, to treat a clinical condition associated with metabolic syndrome as well as diseases manifested by the metabolic syndrome.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: April 15, 2014
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Gabriela Garcia, Richard J. Johnson, Christopher J. Rivard, Miguel A. Lanaspa-Garcia
  • SELECTIVE AMPD2 INHIBITORS AND METHODS FOR USING THE SAME
    Publication number: 20130209484
    Abstract: The present invention provides compounds and compositions that modulate adenosine monophosphate deaminase (AMPD) and methods for using the same to treat a clinical condition associated with the metabolic syndrome or a disease associated with the metabolic syndrome. In particular, the present invention provides a compound and a composition comprising a selective AMPD2 inhibitor and methods for using the same, for example, to treat a clinical condition associated with metabolic syndrome as well as diseases manifested by the metabolic syndrome.
    Type: Application
    Filed: January 13, 2011
    Publication date: August 15, 2013
    Inventors: Gabriela Garcia, Richard J. Johnson, Christopher J. Rivard, Miguel A. Lanaspa-Garcia
  • Pretreatment of high solid microbial sludges
    Patent number: 5785852
    Abstract: A process and apparatus for pretreating microbial sludges in order to enhance secondary anaerobic digestion. The pretreatment process involves disrupting the cellular integrity of municipal sewage sludge through a combination of thermal, explosive decompression and shear forces. The sludge is pressurized and pumped to a pretreatment reactor where it is mixed with steam to heat and soften the sludge. The pressure of the sludge is suddenly reduced and explosive decompression forces are imparted which partially disrupt the cellular integrity of the sludge. Shear forces are then applied to the sludge to further disrupt the cellular integrity of the sludge. Disrupting cellular integrity releases both soluble and insoluble organic constituents and thereby renders municipal sewage sludge more amenable to secondary anaerobic digestion.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: July 28, 1998
    Assignee: Midwest Research Institute
    Inventors: Christopher J. Rivard, Nicholas J. Nagle
  • Pretreatment of microbial sludges
    Patent number: 5380445
    Abstract: Methods are described for pretreating microbial sludges to break cells and disrupt organic matter. One method involves the use of sonication, and another method involves the use of shear forces. The pretreatment of sludge enhances bioconversion of the organic fraction. This allows for efficient dewatering of the sludge and reduces the cost for final disposal of the waste.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: January 10, 1995
    Assignee: Midwest Research Institute
    Inventors: Christopher J. Rivard, Nicholas J. Nagle